NHS National Framework for Edoxaban

NHS England

Value
£8,640,000
Published
10 Nov 2026
Deadline
Not stated
Procedure
Open procedure
Category
33600000 — Pharmaceutical products
Location
UKC, United Kingdom
Notice reference
106853-2026

Requirements summary

NHS England is planning an open-procedure framework agreement for edoxaban, a pharmaceutical product, under a single lot with an estimated value of GBP 7.2m net (GBP 8.64m gross). The planned contract runs from 1 January 2028 to 31 December 2028, with renewal options up to 31 December 2030. The notice is a pipeline notice inviting suppliers planning to introduce edoxaban, or with questions, to contact the MPSC New Market Developments Team.

Key requirements

  • Framework agreement for edoxaban supply under Lot 1, with a planned start on 1 January 2028 and end on 31 December 2028
  • Optional renewal to a maximum extent date of 31 December 2030
  • Delivery across seven English regions (UKC, UKD, UKF, UKG, UKH, UKJ, UKK)
  • Estimated value of GBP 7.2m net (GBP 8.64m gross), procured through an open procedure
  • Suitable for small and medium-sized enterprises (SMEs)
  • Suppliers planning to introduce edoxaban or with questions should contact the MPSC New Market Developments Team before the future notice date of 4 May 2027
NHS National Framework for Edoxaban — NHS England | ProposAI